tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
NewAmsterdam Pharma reports Q2 revenue $19.145M vs $2.279M last year
PremiumThe FlyNewAmsterdam Pharma reports Q2 revenue $19.145M vs $2.279M last year
2d ago
Buy Rating for NewAmsterdam Pharma: Promising Developments in Alzheimer’s and Cardiovascular Trials
Premium
Ratings
Buy Rating for NewAmsterdam Pharma: Promising Developments in Alzheimer’s and Cardiovascular Trials
7d ago
Promising Alzheimer’s Biomarker Data and Expert Enthusiasm Drive Buy Rating for NewAmsterdam Pharma
Premium
Ratings
Promising Alzheimer’s Biomarker Data and Expert Enthusiasm Drive Buy Rating for NewAmsterdam Pharma
8d ago
NewAmsterdam Pharma participates in a conference call with Cantor Fitzgerald
PremiumThe FlyNewAmsterdam Pharma participates in a conference call with Cantor Fitzgerald
1M ago
NewAmsterdam Pharma initiated with a Buy at Citi
Premium
The Fly
NewAmsterdam Pharma initiated with a Buy at Citi
2M ago
Strong Buy Recommendation for NewAmsterdam Pharma Driven by Promising Cardiovascular and Alzheimer’s Opportunities
Premium
Ratings
Strong Buy Recommendation for NewAmsterdam Pharma Driven by Promising Cardiovascular and Alzheimer’s Opportunities
2M ago
NewAmsterdam Pharma Announces Positive Phase 3 Trial Results
PremiumCompany AnnouncementsNewAmsterdam Pharma Announces Positive Phase 3 Trial Results
2M ago
NewAmsterdam Pharma announces topline data from BROADWAY clinical trial
Premium
The Fly
NewAmsterdam Pharma announces topline data from BROADWAY clinical trial
2M ago
NewAmsterdam Pharma Approves Key Proposals at AGM
Premium
Company Announcements
NewAmsterdam Pharma Approves Key Proposals at AGM
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100